Status:
UNKNOWN
Abnormal Coronary Vasomotion in Patients With Suspected Coronary Artery Disease (CAD)
Lead Sponsor:
Peter Ong, MD
Collaborating Sponsors:
Deutsche Stiftung für Herzforschung
Conditions:
Coronary Vasospasm
Microvascular Angina
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
In patients with chest pain and/or shortness of breath coronary artery disease (CAD) is suspected depending on the pattern of symptoms and the electrocardiogram (ECG). Coronary angiography is the meth...
Eligibility Criteria
Inclusion
- Adults between 35 and 95 years old with angina pectoris and/or dyspnea suggestive of coronary artery disease with non-invasive proof of coronary ischemia or high pre-test probability for CAD who will be referred for coronary angiography
- Serum creatinine \< 1,4 md/dl
- Left ventricular ejection fraction \> 50%
Exclusion
- Patients under 35 years and above 95 years of age
- Severe chronic obstructive pulmonary disease (contraindication for acetylcholine-testing)
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00921856
Start Date
November 1 2007
End Date
December 1 2025
Last Update
May 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Bosch Medical Center
Stuttgart, Germany, 70376